Elinore McCance-Katz

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Elinore McCance-Katz
Elinore McCance-Katz official photo.jpg
Assistant Secretary of Health and Human Services for Mental Health and Substance Use
In office
September 11, 2017 – January 7, 2021
PresidentDonald Trump
Chief Medical Officer at Substance Abuse and Mental Health Services Administration
In office
2013–2015
PresidentBarack Obama
Personal details
EducationEastern Connecticut State University (B.A.)
Yale University (MPhil, Ph.D.)
University of Connecticut School of Medicine (M.D.)

Elinore F. McCance-Katz is an American physician, academic, and government official who served as Assistant Secretary of Health and Human Services for Mental Health and Substance Use from 2017 to 2021. Prior to assuming her current role, she was the chief medical officer for the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities, and Hospitals and a professor at the Alpert Medical School at Brown University.[1][2] Her nomination was supported by the American Psychiatric Association, which released a statement saying "Dr. McCance-Katz has a wealth of experience in academic and public sector settings in addressing mental health and substance use disorders."[3]

McCance-Katz resigned in the wake of the 2021 storming of the United States Capitol, on January 7, 2021.[4]

After her 2021 resignation, McCance-Katz was hired into a senior civil service job by the Drug Enforcement Agency. [5]

Education[edit]

McCance-Katz earned a B.A. in biology from Eastern Connecticut State University in 1978. She went on to attend Yale University, where she received an MPhil and Ph.D. She attended medical school at the University of Connecticut School of Medicine, where she earned her M.D. in 1987. She completed her residency in psychiatry at Hartford Hospital in Connecticut.[6][7]

Career[edit]

McCance-Katz was on the faculty of Yale University from 1991 to 1998 and later taught at the University of Texas, the Albert Einstein College of Medicine, Virginia Commonwealth University, and the University of California San Francisco. McCance-Katz was medical director for the California Department of Alcohol and Drug Programs before serving as the first chief medical officer for the Substance Abuse and Mental Health Services Administration, a position which she held from 2013 to 2015. She is a Distinguished Fellow of the American Academy of Addiction Psychiatry.[8] McCance-Katz and her husband hold a patent for a method used to prevent urine specimen substitution in substance use screening.[7] She has conducted substantial research into addiction, specifically opioid addiction.[6]

Political controversies[edit]

McCance-Katz’s work in the Trump administration was marked by several controversial statements. For example, in 2018, McCance-Katz spoke out against fentanyl test strips for people who use drugs. As she wrote in an HHS-sponsored blog, “The entire approach is based on the premise that a drug user poised to use a drug is making rational choices, is weighing pros and cons, and is thinking completely logically about his or her drug use. Based on my clinical experience, I know this could not be further from the truth.”[9] At the same time, however, a study in the International Journal of Drug Policy came to the opposite conclusion. [10] As pointed out in a 2017 New York Times article, the treatment of drug addiction has long been marked by a split between “a medical model of psychiatry, which emphasizes drug and hospital treatment and which Dr. McCance-Katz has promoted, and the so-called psychosocial, which puts more emphasis on community care and support from family and peers.” [11]

In September 2020, during the height of the covid epidemic and just prior to the 2020 presidential election, McCance-Katz spoke on a podcast posted on the official HHS website: “What is this nonsense that somehow it’s unsafe to return to school?... There was no agreement to this, to this nonstop restriction and quarantining and isolation and taking away anything that makes people happy.... You can’t go to a movie, you can’t go to a football game.... We shut down the entire country before the virus, in my opinion, had a chance to get around the entire country. … We used a sledgehammer when I think we needed a scalpel.” [12] As she asserted, “I just wish that the media would get honest about its coverage of Covid.... lost in all of this response to Covid and nonstop 24/7 horrors of Covid and if you can't find something to talk about, it appears to me they make things up. It just does.”[13]

References[edit]

  1. ^ "President Donald J. Trump Announces Intent to Nominate Personnel to Key Administration Posts". whitehouse.gov. April 21, 2017. Retrieved 19 May 2017 – via National Archives.
  2. ^ "Elinore McCance-Katz chosen for new HHS mental health post". Modern Healthcare. April 29, 2017. Retrieved 19 May 2017.
  3. ^ "APA Supports Nomination of Dr. McCance-Katz; Urges Senate to Confirm". American Psychiatric Association. April 25, 2017. Retrieved 19 May 2017.
  4. ^ Bennett, Kate (January 7, 2021). "Trump's assistant secretary for Department of Health and Human Services submits resignation". CNN. Retrieved January 7, 2021.
  5. ^ [1]
  6. ^ a b Blair, Russell (April 25, 2017). "Trump Pick For Mental Health Post Has Connecticut Ties". Hartford Courant. Retrieved 19 May 2017.
  7. ^ a b Straehley, Steve (May 19, 2017). "Assistant Secretary of the Substance Abuse and Mental Health Administration: Who Is Elinore McCance-Katz?". AllGov. Retrieved 19 May 2017.
  8. ^ Gardner, Christopher (April 27, 2017). "Former Psychiatry faculty member Elinore F. McCance-Katz nominated for federal post". Yale School of Medicine. Retrieved 19 May 2017.
  9. ^ "For Beating the Opioid Crisis, America has Better Weapons than Fentanyl Test Strips | SAMHSA Blog".
  10. ^ Krieger, M. S.; Goedel, W. C.; Buxton, J. A.; Lysyshyn, M.; Bernstein, E.; Sherman, S. G.; Rich, J. D.; Hadland, S. E.; Green, T. C.; Marshall, B. D. (2018). "Use of Rapid Fentanyl Test Strips Among Young Adults Who Use Drugs". The International Journal on Drug Policy. 61: 52–58. doi:10.1016/j.drugpo.2018.09.009. PMC 6701177. PMID 30344005.
  11. ^ Benedict, Carey (May 24, 2017). "Trump's Pick for Mental Health 'Czar' Highlights Rift". New York Times. Retrieved 20 June 2021.
  12. ^ Insinger, Alison (September 15, 2020). "Top health official echoes Trump's Covid-19 views, drawing accusations of politicizing U.S. mental health agency". Boston Globe. Retrieved 20 June 2021.
  13. ^ "Trump mental health official accuses media of overblowing dangers of Covid-19".

External links[edit]